Literature DB >> 21181211

Induction of microsomal triglyceride transfer protein expression is a candidate mechanism by which ezetimibe therapy might exert beneficial effects in patients with nonalcoholic steatohepatitis.

Masato Yoneda, Koji Fujita, Kento Imajo, Hironori Mawatari, Hiroyuki Kirikoshi, Satoru Saito, Atsushi Nakajima.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21181211     DOI： 10.1007/s00535-010-0356-8

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN： 0944-1174            Impact factor:   7.527


× No keyword cloud information.
  6 in total

1.  Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption.

Authors:  Scott W Altmann; Harry R Davis; Li-Ji Zhu; Xiaorui Yao; Lizbeth M Hoos; Glen Tetzloff; Sai Prasad N Iyer; Maureen Maguire; Andrei Golovko; Ming Zeng; Luquan Wang; Nicholas Murgolo; Michael P Graziano
Journal:  Science       Date:  2004-02-20       Impact factor: 47.728

2.  Ezetimibe decreases SREBP-1c expression in liver and reverses hepatic insulin resistance in mice fed a high-fat diet.

Authors:  Tomonori Muraoka; Kazutaka Aoki; Tomoyuki Iwasaki; Kazuaki Shinoda; Akinobu Nakamura; Hiroyuki Aburatani; Shuuichi Mori; Kumpei Tokuyama; Naoto Kubota; Takashi Kadowaki; Yasuo Terauchi
Journal:  Metabolism       Date:  2010-08-02       Impact factor: 8.694

3.  Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease.

Authors:  Hyohun Park; Toshihide Shima; Kanji Yamaguchi; Hironori Mitsuyoshi; Masahito Minami; Kohichiroh Yasui; Yoshito Itoh; Toshikazu Yoshikawa; Michiaki Fukui; Goji Hasegawa; Naoto Nakamura; Mitsuhiro Ohta; Hiroshi Obayashi; Takeshi Okanoue
Journal:  J Gastroenterol       Date:  2010-07-24       Impact factor: 7.527

4.  Efficacy of ezetimibe for the treatment of non-alcoholic steatohepatitis: An open-label, pilot study.

Authors:  Masato Yoneda; Koji Fujita; Yuichi Nozaki; Hiroki Endo; Hirokazu Takahashi; Kunihiro Hosono; Kaori Suzuki; Hironori Mawatari; Hiroyuki Kirikoshi; Masahiko Inamori; Satoru Saito; Tomoyuki Iwasaki; Yasuo Terauchi; Kensuke Kubota; Shiro Maeyama; Atsushi Nakajima
Journal:  Hepatol Res       Date:  2010-04-14       Impact factor: 4.288

5.  Inhibition of hepatic Niemann-Pick C1-like 1 improves hepatic insulin resistance.

Authors:  Mitsunori Nomura; Hideto Ishii; Akio Kawakami; Masayuki Yoshida
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-08-04       Impact factor: 4.310

6.  Dysfunctional very-low-density lipoprotein synthesis and release is a key factor in nonalcoholic steatohepatitis pathogenesis.

Authors:  Koji Fujita; Yuichi Nozaki; Koichiro Wada; Masato Yoneda; Yoko Fujimoto; Mihoyo Fujitake; Hiroki Endo; Hirokazu Takahashi; Masahiko Inamori; Noritoshi Kobayashi; Hiroyuki Kirikoshi; Kensuke Kubota; Satoru Saito; Atsushi Nakajima
Journal:  Hepatology       Date:  2009-09       Impact factor: 17.425
  6 in total
  2 in total

1.  Physiological role of hepatic NPC1L1 in human cholesterol and lipoprotein metabolism: new perspectives and open questions.

Authors:  Philip N Howles; David Y Hui
Journal:  J Lipid Res       Date:  2012-08-31       Impact factor: 5.922

Review 2.  Management of nonalcoholic fatty liver disease: an evidence-based clinical practice review.

Authors:  Juan P Arab; Roberto Candia; Rodrigo Zapata; Cristián Muñoz; Juan P Arancibia; Jaime Poniachik; Alejandro Soza; Francisco Fuster; Javier Brahm; Edgar Sanhueza; Jorge Contreras; M Carolina Cuellar; Marco Arrese; Arnoldo Riquelme
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.